Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
1-min read

Aurobindo Pharma Shares Tank 7% After USFDA Action

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

Trending Desk

Updated:May 17, 2019, 11:39 AM IST
facebookTwitterskypewhatsapp
Aurobindo Pharma Shares Tank 7% After USFDA Action
Image for representation only.
Loading...

Aurobindo Pharma shares tanked nearly 7% in early trade on Friday after the US Food and Drug Administration (USFDA) classified its inspection of the company’s API intermediates facilities of Unit I, IX and XI as Official Action Indicated (OAI).

OAI means a USFDA inspection revealed significant objectionable conditions or practices and action must be taken to address the issues. It also indicates that approvals of pending applications or supplements from the site maybe withheld.

“The company has received letters from the USFDA classifying the inspections concluded at our API (active pharmaceutical ingredients) facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated.” the regulatory fiing said.

The company has already submitted its initial response to USFDA, Aurobindo Pharma said in the release.

The company is sending further updates on the committed corrective actions.

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

Shares of Aurobindo Pharma were trading at Rs 678.35, down 6.6%, at 10:47am on BSE.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
Yes Bank 64.10 -1.54
Maruti Suzuki 6,095.05 -0.58
BPCL 382.10 3.62
HDFC 1,988.30 -0.40
Reliance 1,205.70 0.69
Company Price Change %Gain
Maruti Suzuki 6,093.55 -0.61
Yes Bank 64.10 -1.61
ICICI Bank 399.15 -0.36
HDFC 1,988.75 -0.39
Tata Motors 121.85 -0.08
Top Gainers
Company Price Change %Gain
Tata Steel 358.25 3.86
BPCL 382.10 3.62
Vedanta 149.70 2.96
JSW Steel 221.40 2.41
IOC 128.15 2.36
Company Price Change %Gain
Tata Steel 358.05 3.95
Vedanta 149.45 2.68
SBI 280.50 2.41
Bajaj Finance 3,415.05 1.47
NTPC 122.40 1.28
Top Losers
Company Price Change %Gain
Britannia 2,613.85 -2.92
Coal India 192.35 -2.66
ONGC 127.00 -2.08
Eicher Motors 16,030.40 -1.56
Yes Bank 64.10 -1.54
Company Price Change %Gain
Coal India 192.50 -2.58
ONGC 127.00 -2.08
Yes Bank 64.10 -1.61
Bharti Airtel 335.75 -1.21
HDFC Bank 2,186.95 -0.98

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results